Trial Outcomes & Findings for Buttonhole Versus Step Ladder Cannulation in High Dose Hemodialysis (NCT NCT01962025)

NCT ID: NCT01962025

Last Updated: 2020-09-29

Results Overview

The percent of qualified patients enrolled in the study for the pilot study to be successful will be ≥70%. If we can not reach this target we will not move forward with the definitive study. The pilot study will also allow us to see if we can coordinate multiple sites in needling techniques and determine if we can move forward with the definitive study.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

14 participants

Primary outcome timeframe

2 years

Results posted on

2020-09-29

Participant Flow

Participant milestones

Participant milestones
Measure
Buttonhole Needling Technique
The intervention is the Buttonhole needling technique for home hemodialysis Buttonhole needling technique: the intervention is the type of needling used for home hemodialysis patients. They will be randomized to either buttonhole cannulation or stepladder cannulation In the buttonhole technique, a constant site is used for needle placement that ultimately results in a fibrous tract. Once the tract has formed blunt needles can be used instead of sharp needles for each treatment. The presence of a tract may simplify the needle insertion technique and lead to enhanced patient confidence with needle placement.
Step Ladder Group
Patients will use step ladder needling technique (i.e., sites will be rotated with needles placed at least 2-3cms between needle tips).
Overall Study
STARTED
8
6
Overall Study
COMPLETED
8
6
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Buttonhole Versus Step Ladder Cannulation in High Dose Hemodialysis

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Buttonhole Needling Technique
n=8 Participants
The intervention is the Buttonhole needling technique for home hemodialysis. Buttonhole needling technique: the intervention is the type of needling used for home hemodialysis patients. They will be randomized to either buttonhole cannulation or stepladder cannulation. In the buttonhole technique, a constant site is used for needle placement that ultimately results in a fibrous tract. Once the tract has formed blunt needles can be used instead of sharp needles for each treatment. The presence of a tract may simplify the needle insertion technique and lead to enhanced patient confidence with needle placement.
Step Ladder Group
n=6 Participants
Patients will use step ladder needling technique (i.e., sites will be rotated with needles placed at least 2-3 cms between needle tips).
Total
n=14 Participants
Total of all reporting groups
Age, Continuous
50.1 years
STANDARD_DEVIATION 13.6 • n=5 Participants
50.8 years
STANDARD_DEVIATION 16.0 • n=7 Participants
50.4 years
STANDARD_DEVIATION 14.1 • n=5 Participants
Sex: Female, Male
Female
1 Participants
n=5 Participants
3 Participants
n=7 Participants
4 Participants
n=5 Participants
Sex: Female, Male
Male
7 Participants
n=5 Participants
3 Participants
n=7 Participants
10 Participants
n=5 Participants
Race/Ethnicity, Customized
Caucasian
6 Participants
n=5 Participants
5 Participants
n=7 Participants
11 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Race/Ethnicity, Customized
Other
1 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
Region of Enrollment
Canada
8 participants
n=5 Participants
6 participants
n=7 Participants
14 participants
n=5 Participants
Etiology renal disease
Diabetes mellitus
3 Participants
n=5 Participants
1 Participants
n=7 Participants
4 Participants
n=5 Participants
Etiology renal disease
Polycystic kidney disease
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Etiology renal disease
Glomerulonephritis
0 Participants
n=5 Participants
1 Participants
n=7 Participants
1 Participants
n=5 Participants
Etiology renal disease
Other
5 Participants
n=5 Participants
4 Participants
n=7 Participants
9 Participants
n=5 Participants
End Stage Renal Disease (ESRD) Vintage
8.0 years
STANDARD_DEVIATION 11.1 • n=5 Participants
6.0 years
STANDARD_DEVIATION 6.1 • n=7 Participants
6.7 years
STANDARD_DEVIATION 9.7 • n=5 Participants
Previous access
Had 1 Central Venous Catheter (CVC)
2 participants
n=5 Participants
1 participants
n=7 Participants
3 participants
n=5 Participants
Previous access
Had >1 CVC
4 participants
n=5 Participants
3 participants
n=7 Participants
7 participants
n=5 Participants
Previous access
No CVC
1 participants
n=5 Participants
2 participants
n=7 Participants
3 participants
n=5 Participants
Previous access
Had 1 Arteriovenous Fistula or Graft (AVF/AVG)
2 participants
n=5 Participants
0 participants
n=7 Participants
2 participants
n=5 Participants
Previous access
Had 1+ AVF/AVG
0 participants
n=5 Participants
1 participants
n=7 Participants
1 participants
n=5 Participants
Previous access
No AVF/AVG
5 participants
n=5 Participants
5 participants
n=7 Participants
10 participants
n=5 Participants

PRIMARY outcome

Timeframe: 2 years

Population: Intent to Treat (ITT)

The percent of qualified patients enrolled in the study for the pilot study to be successful will be ≥70%. If we can not reach this target we will not move forward with the definitive study. The pilot study will also allow us to see if we can coordinate multiple sites in needling techniques and determine if we can move forward with the definitive study.

Outcome measures

Outcome measures
Measure
Buttonhole Needling Technique
n=8 Participants
the intervention is the Buttonhole needling technique for home hemodialysis Buttonhole needling technique: the intervention is the type of needling used for home hemodialysis patients. They will be randomized to either buttonhole cannulation or stepladder cannulation
Step Ladder Group
n=6 Participants
Patients will use step ladder needling technique
Feasibility of Participant Recruitment and Site Coordination
8 Participants
6 Participants

SECONDARY outcome

Timeframe: Up to 90 days

Population: Intent to Treat (ITT)

Time in Days that it takes to train participants to perform home hemodialysis (document time in days from start of training until discharge home to do self-care). Unit of measure is number of days required to independently perform home hemodialysis

Outcome measures

Outcome measures
Measure
Buttonhole Needling Technique
n=8 Participants
the intervention is the Buttonhole needling technique for home hemodialysis Buttonhole needling technique: the intervention is the type of needling used for home hemodialysis patients. They will be randomized to either buttonhole cannulation or stepladder cannulation
Step Ladder Group
n=6 Participants
Patients will use step ladder needling technique
Participant Training Time
19 days
Standard Deviation 5
29 days
Standard Deviation 14

SECONDARY outcome

Timeframe: 12 Months

Population: No formal costing information was collected as the data linkages were not established for the feasibility trial period.

Will incorporate the cost of training and complications

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: 12 Months

Population: Intent to Treat (ITT)

To determine whether buttonhole cannulation, compared to step-ladder cannulation, is associated with reduced complications (infection - local and systemic, radiologic/surgical interventions, re-trains for needle insertion difficulties, hematoma formation, aneurysm formation, missed insertions).

Outcome measures

Outcome measures
Measure
Buttonhole Needling Technique
n=8 Participants
the intervention is the Buttonhole needling technique for home hemodialysis Buttonhole needling technique: the intervention is the type of needling used for home hemodialysis patients. They will be randomized to either buttonhole cannulation or stepladder cannulation
Step Ladder Group
n=6 Participants
Patients will use step ladder needling technique
Number of Participants With Complications
Hematoma
1 Participants
5 Participants
Number of Participants With Complications
Infection - local and systemic
0 Participants
0 Participants
Number of Participants With Complications
Contact dermatitis
3 Participants
1 Participants
Number of Participants With Complications
Stenosis Requiring Angioplasty
4 Participants
3 Participants
Number of Participants With Complications
Aneurysm
3 Participants
0 Participants
Number of Participants With Complications
Radiologic/surgical interventions
2 Participants
0 Participants
Number of Participants With Complications
Re-training for needle insertion difficulties
0 Participants
0 Participants
Number of Participants With Complications
Missed insertions
8 Participants
6 Participants

SECONDARY outcome

Timeframe: baseline, end of training (2 months), and 2 months after graduating training (4 months)

Population: Intent to Treat (ITT)

Pain/discomfort during cannulation will be measured using a 10cm (0 mm to 100 mm) visual analogue scale, which ranges from "No Pain" (0 mm) on the left side to "Extreme Pain" (100 mm) on the right. The participant is instructed to place a mark on the scale according to the amount of pain felt during needling the fistula that day. The visual analogue scale with be completed at baseline, end of training, and 2 months after graduating training. The mean of these three assessments will be calculated.

Outcome measures

Outcome measures
Measure
Buttonhole Needling Technique
n=8 Participants
the intervention is the Buttonhole needling technique for home hemodialysis Buttonhole needling technique: the intervention is the type of needling used for home hemodialysis patients. They will be randomized to either buttonhole cannulation or stepladder cannulation
Step Ladder Group
n=6 Participants
Patients will use step ladder needling technique
Pain With Needling
17.4 mm
Standard Deviation 25.1
10.7 mm
Standard Deviation 7.9

Adverse Events

Buttonhole Needling Technique

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Step Ladder Group

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Deborah Zimmerman

Ottawa HRI

Phone: 613-722-7000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place